Burcon Prices Prospectus Offering

VANCOUVER, Nov. 16, 2012 /CNW/ - Burcon NutraScience Corporation (TSX- BU; 
NASDAQ - BUR) ("Burcon" or the "Corporation") is pleased to announce that, 
further to its press release dated November 7, 2012, it has entered into an 
agency agreement (the"Agency Agreement") with NCP Northland Capital Partners 
Inc. as lead agent and Raymond James Ltd. (together the "Agents"). Under the 
terms of the Agency Agreement, the Agents will offer (the"Offering"), on a 
best efforts basis, up to 1,437,500 common shares at a price of $4.00 per 
common share (the "Issue Price") for gross proceeds of up to $5,750,000. The 
size of the Offering has increased by $750,000 from $5,000,000 as previously 
announced by the Corporation on November 7, 2012. 
The Corporation anticipates filing a final short form prospectus (the "Final 
Prospectus") today with the securities regulatory authorities in the Provinces 
of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick 
and Nova Scotia in connection with the Offering. The Offering is expected to 
close on or about November 23, 2012. 
ITC Corporation Limited, Burcon's largest shareholder, has advised the 
Corporation that it will subscribe for 300,000 common shares in the Offering. 
Closing is subject to certain conditions, including, but not limited to, the 
receipt of all necessary approvals including the approval of the applicable 
securities regulatory authorities and the TSX. 
The net proceeds of the Offering will be used for continued commercialization 
of Burcon's uniquely soluble and clean-tasting Peazazz™ pea protein, 
CLARISOY™ soy protein and for general working capital purposes, all as more 
particularly set out in the Final Prospectus. 
This press release is not an offer to sell or the solicitation of an offer to 
buy the securities in any jurisdiction in which such offer, solicitation or 
sale would be unlawful prior to qualification or registration under the 
securities laws of such jurisdiction. The securities being offered have not 
been, nor will they be, registered under the United States Securities Act of 
1933, as amended, and such securities may not be offered or sold within the 
United States or to, or for the account or benefit of, U.S. persons absent 
registration or an applicable exemption from U.S. registration requirements. 
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of 
functional, renewable plant proteins. Since 1999, Burcon has developed a 
portfolio of composition, application, and process patents originating from 
our core protein extraction and purification technology. We have developed 
CLARISOY™ soy protein, which offers clarity and complete protein nutrition 
for low pH beverage systems; Peazazz™ a uniquely soluble and clean-tasting 
pea protein and Puratein®, Supertein™ and Nutratein™ canola protein 
isolates with unique functional and nutritional attributes. Our team of 
highly specialized scientists and engineers work from our private research 
facility to develop and optimize environmentally sound technologies. To date, 
our patent portfolio consists of 212 issued patents in various countries, 
including 35 issued U.S. patents, and in excess of 400 additional pending 
patent applications, 77 of which are U.S. patent applications. 
CLARISOY™ is under license from Archer Daniels Midland Company.
CLARISOY™ is a trademark of Archer Daniels Midland Company. 
"Johann F. Tergesen"
Johann F. Tergesen
President and Chief Operating Officer 
The TSX has not reviewed and does not accept responsibility for the adequacy 
of the content of the information contained herein. This press release 
contains forward-looking statements or forward-looking information. 
Forward-looking statements or forward-looking information involve risks, 
uncertainties and other factors that could cause actual results, performances, 
prospects and opportunities to differ materially from those expressed or 
implied by such forward-looking statements. All statements other than 
statements of historical fact included in this release are forward-looking 
statements, including, without limitation, statements regarding the timing and 
use of proceeds of the Offering and the completion of the Offering. There can 
be no assurance that such statements will prove to be accurate and actual 
results and future events could differ materially from those anticipated in 
such statements or information. Important factors that could cause actual 
results to differ materially from Burcon's plans and expectations include the 
actual results of marketing activities, adverse general economic, market or 
business conditions, regulatory changes and other risks and factors detailed 
herein and from time to time in the filings made by Burcon with securities 
regulators and stock exchanges, including in the section entitled "Risk 
Factors" in Burcon's annual information form dated June 25, 2012. Any 
forward-looking statement or information only speaks as of the date on which 
it was made and, except as may be required by applicable securities laws, 
Burcon disclaims any intent or obligation to update any forward-looking 
statement, whether as a result of new information, future events or otherwise. 
Although Burcon believes that the assumptions inherent in the forward-looking 
statements are reasonable, forward-looking statements are not guarantees of 
future performance and accordingly undue reliance should not be put on such. 
Michael Kirwan, Director, Corporate Development Burcon NutraScience 
Corporation (604) 733-0896 / (888) 408-7960 toll-free 
SOURCE: Burcon NutraScience Corporation 
To view this news release in HTML formatting, please use the following URL: 
CO: Burcon NutraScience Corporation
ST: British Columbia
-0- Nov/16/2012 19:24 GMT
Press spacebar to pause and continue. Press esc to stop.